| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 10.850.119.651 $ | 99,60 | 407.026.215 | |||||||
| ELI LILLY & CO | ELI LILLY & CO | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 1.104.163.650 $ | 10,14 | 1.200.478 | |
| THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 442.858.208 $ | 4,07 | 900.979 | |
| INTUITIVE SURGICAL INC | INTUITIVE SURGICAL INC | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 397.936.249 $ | 3,65 | 863.221 | |
| STRYKER CORP | STRYKER CORP | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 377.064.254 $ | 3,46 | 1.147.522 | |
| MERCK & CO. INC. | MERCK & CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 374.870.794 $ | 3,44 | 3.116.392 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 345.378.567 $ | 3,17 | 1.751.235 | |
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP INC | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 336.306.840 $ | 3,09 | 1.242.865 | |
| ARGENX SE - ADR | ARGENX SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 317.885.128 $ | 2,92 | 435.310 | |
| ABBVIE INC | ABBVIE INC | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 309.562.434 $ | 2,84 | 1.423.341 | |
| REGENERON PHARMACEUTICALS | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 288.369.337 $ | 2,65 | 373.226 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 283.595.093 $ | 2,60 | 2.034.836 | |
| JOHNSON & JOHNSON | JOHNSON & JOHNSON | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 266.037.496 $ | 2,44 | 1.088.355 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 264.036.869 $ | 2,42 | 591.295 | |
| DANAHER CORP | DANAHER CORP | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 222.869.302 $ | 2,05 | 1.175.471 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 175.987.768 $ | 1,62 | 531.894 | |
| ASCENDIS PHARMA A/S - ADR | ASCENDIS PHARMA A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 154.661.050 $ | 1,42 | 676.173 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 147.792.965 $ | 1,36 | 1.519.722 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 146.432.260 $ | 1,34 | 246.943 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 129.161.257 $ | 1,19 | 5.757.796 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 123.200.542 $ | 1,13 | 4.447.673 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THERAPEUTICS INC | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 120.373.019 $ | 1,11 | 1.142.059 | |
| INSMED INC | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 114.904.686 $ | 1,05 | 702.695 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 112.780.204 $ | 1,04 | 5.948.323 | |
| NATERA INC | NATERA INC | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 112.343.583 $ | 1,03 | 561.746 | |
| TENET HEALTHCARE CORP | TENET HEALTHCARE CORP | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 109.471.048 $ | 1,00 | 580.102 | |
| BRIGHTSPRING HEALTH SERVICES | BRIGHTSPRING HEALTH SERVICES INC | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 107.124.821 $ | 0,98 | 2.514.077 | |
| AMGEN INC | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 106.864.586 $ | 0,98 | 303.722 | |
| BOSTON SCIENTIFIC CORP | BOSTON SCIENTIFIC CORP | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 100.636.630 $ | 0,92 | 1.603.771 | |
| HCA HEALTHCARE INC | HCA HEALTHCARE INC | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 97.589.187 $ | 0,90 | 206.215 | |
| GUARDANT HEALTH INC | GUARDANT HEALTH INC | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 97.541.612 $ | 0,90 | 1.055.988 | |
| CVS HEALTH CORP | CVS HEALTH CORP | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 94.108.547 $ | 0,86 | 1.310.339 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 83.487.147 $ | 0,77 | 1.002.367 | |
| CIGNA GROUP/THE | CIGNA GROUP/THE | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 80.106.092 $ | 0,74 | 300.304 | |
| CG ONCOLOGY INC | CG ONCOLOGY INC | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 75.028.221 $ | 0,69 | 1.108.573 | |
| CARDINAL HEALTH INC | CARDINAL HEALTH INC | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 73.584.904 $ | 0,68 | 348.232 | |
| ELEVANCE HEALTH INC | ELEVANCE HEALTH INC | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 71.512.385 $ | 0,66 | 244.278 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 70.637.862 $ | 0,65 | 273.451 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 67.338.385 $ | 0,62 | 1.369.780 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 66.291.179 $ | 0,61 | 882.823 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 64.171.705 $ | 0,59 | 864.149 | |
| CHUGAI PHARMACEUTICAL CO LTD | CHUGAI PHARMACEUTICAL CO LTD | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 62.924.420 $ | 0,58 | 1.141.000 | |
| STRUCTURE THERAPEUTICS INC ADR | STRUCTURE THERAPEUTICS INC | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 61.368.577 $ | 0,56 | 1.273.207 | |
| PRAXIS PRECISION MEDICINES I | PRAXIS PRECISION MEDICINES INC | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 60.990.889 $ | 0,56 | 189.301 | |
| CELCUITY INC | CELCUITY INC | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 60.608.340 $ | 0,56 | 531.000 | |
| ROYALTY PHARMA PLC- CL A | ROYALTY PHARMA PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 59.566.412 $ | 0,55 | 1.241.743 | |
| CENCORA INC | CENCORA INC | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 56.456.298 $ | 0,52 | 179.717 | |
| CENTESSA PHARMACEUTICALS-ADR | CENTESSA PHARMACEUTICALS PLC | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 54.320.158 $ | 0,50 | 1.367.577 | |
| VERA THERAPEUTICS INC | VERA THERAPEUTICS INC | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 49.716.475 $ | 0,46 | 1.235.806 | |
| NUVALENT INC-A | NUVALENT INC | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 47.105.588 $ | 0,43 | 459.791 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 46.722.599 $ | 0,43 | 555.098 | |
| ABIVAX SA-ADR | ABIVAX SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 45.425.678 $ | 0,42 | 407.954 | |
| EDWARDS LIFESCIENCES CORP | EDWARDS LIFESCIENCES CORP | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 45.027.142 $ | 0,41 | 562.277 | |
| CYTOKINETICS INC | CYTOKINETICS INC | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 43.707.294 $ | 0,40 | 663.136 | |
| INCYTE CORP | INCYTE CORP | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 43.374.261 $ | 0,40 | 460.840 | |
| Spyre Therapeutics Inc | SPYRE THERAPEUTICS INC | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 43.083.074 $ | 0,40 | 854.145 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 40.512.380 $ | 0,37 | 482.750 | |
| CRINETICS PHARMACEUTICALS IN | CRINETICS PHARMACEUTICALS INC | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 39.750.642 $ | 0,36 | 1.094.456 | |
| TENAX THERAPEUTICS INC | TENAX THERAPEUTICS INC | EC | 88032L605 | Long | Börsenkurs (Stufe 1) | 39.672.245 $ | 0,36 | 2.481.066 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 39.115.249 $ | 0,36 | 74.723 | |
| IMMUNOME INC | IMMUNOME INC | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 36.426.978 $ | 0,33 | 1.665.614 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS INC | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 35.396.089 $ | 0,32 | 207.553 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 35.127.999 $ | 0,32 | 921.511 | |
| CARIS LIFE SCIENCES INC | CARIS LIFE SCIENCES INC | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 34.148.422 $ | 0,31 | 1.909.867 | |
| BELITE BIO INC - ADR | BELITE BIO INC | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 33.141.517 $ | 0,30 | 207.862 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 30.746.860 $ | 0,28 | 1.869.110 | |
| TERNS PHARMACEUTICALS INC | TERNS PHARMACEUTICALS INC | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 29.367.254 $ | 0,27 | 557.042 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 27.704.068 $ | 0,25 | 163.910 | |
| MODERNA THERAPEUTICS INC | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 26.799.794 $ | 0,25 | 527.555 | |
| NATIONAL RESILIENCE SR B CVT PFD STK PP | NATIONAL RESILIENCE SER B CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 26.349.676 $ | 0,24 | 1.204.832 | |
| ALUMIS INC | ALUMIS INC | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 26.185.365 $ | 0,24 | 1.188.623 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 26.069.829 $ | 0,24 | 1.093.992 | |
| ALIGNMENT HEALTHCARE INC | ALIGNMENT HEALTHCARE INC | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 25.999.808 $ | 0,24 | 1.475.585 | |
| WEST PHARMACEUTICAL SERVICES | WEST PHARMACEUTICAL SERVICES INC | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 24.468.730 $ | 0,22 | 97.625 | |
| SONOVA HOLDING AG-REG | SONOVA HOLDING AG | EC | CH0012549785 | Long | Modellwert (Stufe 2) | 24.062.943 $ | 0,22 | 105.533 | |
| REVVITY INC | REVVITY INC | EC | 714046109 | Long | Börsenkurs (Stufe 1) | 24.029.408 $ | 0,22 | 274.277 | |
| IDEXX LABORATORIES INC | IDEXX LABORATORIES INC | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 23.909.543 $ | 0,22 | 42.552 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 23.348.683 $ | 0,21 | 476.018 | |
| ORIC PHARMACEUTICALS INC | ORIC PHARMACEUTICALS INC | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 22.050.653 $ | 0,20 | 1.740.383 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUTICS INC | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 21.946.990 $ | 0,20 | 547.443 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 21.531.074 $ | 0,20 | 721.309 | |
| MCKESSON CORP | MCKESSON CORP | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 21.220.358 $ | 0,19 | 24.522 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 21.016.996 $ | 0,19 | 241.658 | |
| BILLIONTOONE INC CL A | BILLIONTOONE INC | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 20.877.657 $ | 0,19 | 264.475 | |
| MIRUM PHARMACEUTICALS INC | MIRUM PHARMACEUTICALS INC | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 20.779.033 $ | 0,19 | 224.930 | |
| ERASCA INC | ERASCA INC | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 20.191.232 $ | 0,19 | 1.247.913 | |
| TREELINE BIO SER A-1 CVT PFD STOCK PP | TREELINE BIO SER A-1 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 19.997.649 $ | 0,18 | 2.744.291 | |
| IMMUNOCORE HOLDINGS PLC-ADR | IMMUNOCORE HOLDINGS PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 19.397.545 $ | 0,18 | 643.368 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 19.086.408 $ | 0,18 | 153.120 | |
| ARROWHEAD PHARMACEUTICALS INC | ARROWHEAD PHARMACEUTICALS INC | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 18.889.629 $ | 0,17 | 301.270 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTICS INC | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 18.832.888 $ | 0,17 | 1.215.025 | |
| RAPPORT THERAPEUTICS INC | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 18.808.575 $ | 0,17 | 601.105 | |
| Generate Biomedicines Inc Lockup Shs PP | Generate Biomedicines Inc lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 18.408.413 $ | 0,17 | 1.472.673 | |
| VAXCYTE INC | VAXCYTE INC | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 18.284.021 $ | 0,17 | 314.645 | |
| CELLANOME SERIES A CVT PFD STOCK PP | CELLANOME SERIES A CVT PFD STOCK PP | EP | TC13MXKE8 | Long | Schätzwert (Stufe 3) | beschränkt | 17.342.467 $ | 0,16 | 1.993.387 |
| CENTENE CORP | CENTENE CORP | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 17.330.297 $ | 0,16 | 529.331 | |
| TREELINE BIO SER A CVT PFD STOCK PP | TREELINE BIO SER A CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 17.271.283 $ | 0,16 | 2.370.150 | |
| BIO-RAD LABORATORIES-A | BIO-RAD LABORATORIES INC | EC | 090572207 | Long | Börsenkurs (Stufe 1) | 16.924.864 $ | 0,16 | 60.717 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 16.534.221 $ | 0,15 | 887.029 | |
| NOVO-NORDISK A/S-SPONS ADR | NOVO NORDISK A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 16.422.436 $ | 0,15 | 446.869 | |
| INSITRO SER B CVT PFD PP | INSITRO SER B CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 16.161.650 $ | 0,15 | 883.580 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 15.277.439 $ | 0,14 | 2.107.233 | |
| KESTRA MEDICAL TECHNOLOGIES | KESTRA MEDICAL TECHNOLOGIES LTD | EC | BMG524411052 | Long | Börsenkurs (Stufe 1) | 14.836.091 $ | 0,14 | 744.410 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 14.721.483 $ | 0,14 | 452.134 | |
| ENCOMPASS HEALTH CORP | ENCOMPASS HEALTH CORP | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 14.641.053 $ | 0,13 | 151.360 | |
| BEONE MEDICINES LTD-ADR | BEONE MEDICINES LTD | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 14.618.348 $ | 0,13 | 49.225 | |
| IMMUNOCORE HOLDINGS CB 2.50% 2/30 | IMMUNOCORE HOLDINGS PLC | DBT | 45258DAB1 | Long | Modellwert (Stufe 2) | 13.946.074 $ | 0,13 | 15.469.000 | |
| CHARLES RIVER LABORATORIES | CHARLES RIVER LABORATORIES INTERNATIONAL INC | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 13.736.693 $ | 0,13 | 79.633 | |
| ARSENAL BIOSCIENCES SER C CVT PFD PP | ARSENAL BIOSCIENCES SER C CVT PFD PP | EP | TC5YX3EI8 | Long | Schätzwert (Stufe 3) | beschränkt | 13.459.241 $ | 0,12 | 724.394 |
| DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | EP | TC0LOSSE0 | Long | Schätzwert (Stufe 3) | beschränkt | 13.399.054 $ | 0,12 | 3.426.868 |
| CELLDEX THERAPEUTICS INC | CELLDEX THERAPEUTICS INC | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 13.395.864 $ | 0,12 | 422.316 | |
| TANGO THERAPEUTICS INC | TANGO THERAPEUTICS INC | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 13.357.127 $ | 0,12 | 638.486 | |
| Aktis Oncology Inc. Lockup Shs PP | Aktis Oncology, Inc. IPO | EC | Long | Modellwert (Stufe 2) | beschränkt | 12.968.711 $ | 0,12 | 724.914 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 12.934.622 $ | 0,12 | 1.299.962 | |
| REPLIGEN CORP | REPLIGEN CORP | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 12.810.569 $ | 0,12 | 108.730 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 12.779.603 $ | 0,12 | 642.514 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 12.554.707 $ | 0,12 | 326.181 | |
| VIATRIS INC | VIATRIS INC | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 12.527.012 $ | 0,11 | 927.240 | |
| TARSUS PHARMACEUTICALS INC | TARSUS PHARMACEUTICALS INC | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 12.336.298 $ | 0,11 | 175.856 | |
| OCULAR THERAPEUTIX INC | OCULAR THERAPEUTIX INC | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 12.194.818 $ | 0,11 | 1.439.766 | |
| ENDEAVOR BIO SERIES B CVT PFD STOCK PP | END EAVOR BIO SERIES B CVT PFD STOCK PP | EP | TC0KH48I6 | Long | Schätzwert (Stufe 3) | beschränkt | 12.186.217 $ | 0,11 | 1.867.734 |
| CLEAR LABS SERIES C CVT PFD PP | CLEAR LABS SERIES C CVT PFD PP | EP | TC385IBS6 | Long | Schätzwert (Stufe 3) | beschränkt | 12.119.800 $ | 0,11 | 3.830.773 |
| DISC MEDICINE INC | DISC MEDICINE INC | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 11.931.524 $ | 0,11 | 186.605 | |
| TYRA BIOSCIENCES INC | TYRA BIOSCIENCES INC | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 11.761.241 $ | 0,11 | 307.082 | |
| MOLINA HEALTHCARE INC | MOLINA HEALTHCARE INC | EC | 60855R100 | Long | Börsenkurs (Stufe 1) | 11.417.812 $ | 0,10 | 85.655 | |
| SARTORIUS AG-VORZUG PREF | SARTORIUS AG | EP | DE0007165631 | Long | Modellwert (Stufe 2) | 11.086.853 $ | 0,10 | 44.309 | |
| SEAPORT THERAPEUTICS SER B CVT PFD PP | SEAPORT THERAPEUTICS SER B CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 11.030.493 $ | 0,10 | 2.322.209 | |
| MEDPACE HOLDINGS INC | MEDPACE HOLDINGS INC | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 11.011.717 $ | 0,10 | 22.932 | |
| REPLIMUNE GROUP INC | REPLIMUNE GROUP INC | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 10.922.395 $ | 0,10 | 1.427.764 | |
| INSITRO SER C CVT PFD PP | INSITRO SER C CVT PFD PP | EP | TC3HHHWL7 | Long | Schätzwert (Stufe 3) | beschränkt | 10.762.154 $ | 0,10 | 588.382 |
| GALVANIZE THERA SER C-2 NV CVT PFD PP | Galvanize Therapeutics Series C-2 CVT PFD | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.701.000 $ | 0,10 | 26.100.000 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 10.608.198 $ | 0,10 | 725.099 | |
| KARTOS THERAPEUTICS SR C CVT PFD STK PP | KARTOS THERAPEUTICS SR C CVT PFD STK PP | EP | TC1HQTAC7 | Long | Schätzwert (Stufe 3) | beschränkt | 10.592.823 $ | 0,10 | 1.873.841 |
| BIOHAVEN LTD | BIOHAVEN LTD | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 10.393.567 $ | 0,10 | 1.228.554 | |
| CLEERLY SER C CVT PFD STK PP | CLEERLY SER C CVT PFD STK PP | EP | TC1A1CZJ4 | Long | Schätzwert (Stufe 3) | beschränkt | 10.284.809 $ | 0,09 | 586.029 |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | KARDIUM SERIES D6 CVT PFD STOCK PP | EP | TC0GUUWU8 | Long | Schätzwert (Stufe 3) | beschränkt | 10.193.893 $ | 0,09 | 12.320.393 |
| Genesis Molecular AI Ser B CVT PFD PP | GENESIS THERA SEV B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.151.789 $ | 0,09 | 1.987.585 | |
| THIRD ARC BIO SER A CVT PFD PP | THIRD ARC BIO SER A CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.123.172 $ | 0,09 | 4.810.936 | |
| Climb Bio Inc | CLIMB BIO INC | EC | 28658R106 | Long | Börsenkurs (Stufe 1) | 10.058.656 $ | 0,09 | 1.468.417 | |
| Mirum Pharma 6 month Lockup Shs PP | MIRUM PHARMA 6 MONTH LOCKUP SHS PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 9.863.722 $ | 0,09 | 112.393 | |
| Mirum Pharma 9 month Lockup Shs PP | MIRUM PHARMA 9 MONTH LOCKUP SHS PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 9.863.722 $ | 0,09 | 112.393 | |
| KYVERNA THERAPEUTICS INC | KYVERNA THERAPEUTICS INC | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 9.856.849 $ | 0,09 | 1.142.161 | |
| LIQUIDIA CORP | LIQUIDIA CORP | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 9.836.025 $ | 0,09 | 260.626 | |
| Cullinan Therapeutics Inc | CULLINAN THERAPEUTICS INC | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 9.758.916 $ | 0,09 | 686.764 | |
| OLEMA PHARMACEUTICALS INC | OLEMA PHARMACEUTICALS INC | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 9.679.289 $ | 0,09 | 649.181 | |
| PHARVARIS NV | PHARVARIS NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 9.365.694 $ | 0,09 | 331.529 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 9.347.635 $ | 0,09 | 3.830.998 | |
| NATIONAL RESILIENCE SR C CVT PFD STK PP | NATIONAL RESILIENCE SER C CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 9.335.319 $ | 0,09 | 426.855 | |
| LANTHEUS HOLDINGS INC | LANTHEUS HOLDINGS INC | EC | 516544103 | Long | Börsenkurs (Stufe 1) | 9.266.595 $ | 0,09 | 122.170 | |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 8.988.077 $ | 0,08 | 468.129 | |
| ATRIUM THERAPEUTICS INC | ATRIUM THERAPEUTICS INC | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 8.908.765 $ | 0,08 | 666.325 | |
| OBSIDIAN THERAPEUTIC SR C CVT PFD STK PP | OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 8.821.048 $ | 0,08 | 4.647.794 | |
| SHATTUCK LABS INC | SHATTUCK LABS INC | EC | 82024L103 | Long | Börsenkurs (Stufe 1) | 8.785.232 $ | 0,08 | 1.366.288 | |
| Kailera Therapeutics SER B CVT PFD PP | KAILERA THERAPEUTICS SER B CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 8.773.842 $ | 0,08 | 626.703 | |
| IDEAYA BIOSCIENCES INC | IDEAYA BIOSCIENCES INC | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 8.634.645 $ | 0,08 | 259.143 | |
| SENSORION SA | SENSORION SA | EC | FR0012596468 | Long | Modellwert (Stufe 2) | 8.048.742 $ | 0,07 | 16.950.906 | |
| Kardium Inc Series D-7 CVT PFD Stock PP | Kardium, Inc. Series D-7 CVT Pfd Stock | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.799.613 $ | 0,07 | 12.050.573 | |
| NCHROMA BIO SER I CVT PFD STOCK PP | CHROMA MEDICINE SER I CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.683.800 $ | 0,07 | 7.683.800 | |
| SPYGLASS PHARMA INC | SPYGLASS PHARMA INC | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 7.534.421 $ | 0,07 | 290.792 | |
| KARDIUM INC SER D-5 CVT PFD STOCK PP | KARDIUM INC SER D-5 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.249.147 $ | 0,07 | 8.849.057 | |
| DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | EP | TC7ZV25B2 | Long | Schätzwert (Stufe 3) | beschränkt | 7.245.770 $ | 0,07 | 1.853.138 |
| PROCEPT BIOROBOTICS CORP | PROCEPT BIOROBOTICS CORP | EC | 74276L105 | Long | Börsenkurs (Stufe 1) | 7.243.721 $ | 0,07 | 289.633 | |
| IOVANCE BIOTHERAPEUTICS INC | IOVANCE BIOTHERAPEUTICS INC | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 7.185.135 $ | 0,07 | 2.047.047 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 6.725.628 $ | 0,06 | 343.846 | |
| AVALYN PHARMA SER C-1 CVT PFD STOCK PP | AVALYN PHARMA SER C-1 CVT PFD STOCK PP | EP | TC6KYIDL7 | Long | Schätzwert (Stufe 3) | beschränkt | 6.717.715 $ | 0,06 | 8.436.161 |
| SCRIBE THERA SER B CVT PFD STOCK PP | SCRIBE THERA SER B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 6.219.254 $ | 0,06 | 1.027.755 | |
| PARABILIS MED INC SER F CVT PFD PP | PARABILIS MED INC SER F CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 6.125.490 $ | 0,06 | 993.688 | |
| ALTO NEUROSCIENCE INC | ALTO NEUROSCIENCE INC | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 6.030.934 $ | 0,06 | 268.280 | |
| INSPIRE MEDICAL SYSTEMS INC | INSPIRE MEDICAL SYSTEMS INC | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 5.991.533 $ | 0,06 | 116.160 | |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 5.970.698 $ | 0,05 | 333.745 | |
| COLOR HEALTH SR D-1 CVT PFD STOCK PP | COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | EP | TC3KSMZE0 | Long | Schätzwert (Stufe 3) | beschränkt | 5.913.622 $ | 0,05 | 438.696 |
| ELEMENT BIOSCIENCES SER C CVT PFD STOCK PP | ELEMENT BIOSCIENCES SER C CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.907.949 $ | 0,05 | 861.217 | |
| COLOR HEALTH SR D CVT PFD STOCK PP | COLOR HEALTH SER D CVT PFD STOCK PP | EP | TC1HL9RU8 | Long | Schätzwert (Stufe 3) | beschränkt | 5.697.933 $ | 0,05 | 296.922 |
| EVOMMUNE INC | EVOMMUNE INC | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 5.657.655 $ | 0,05 | 246.092 | |
| Galvanize Therapeutics Ser C CVT PFD PP | GALVANIZE THERAPEUTICS SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.440.893 $ | 0,05 | 13.270.470 | |
| IMMATICS NV | IMMATICS NV | EC | N44445109 | Long | Börsenkurs (Stufe 1) | 4.874.667 $ | 0,04 | 495.393 | |
| XENCOR INC | XENCOR INC | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 4.565.627 $ | 0,04 | 378.576 | |
| FREENOME HOLDINGS SER B CVT PFD PP | FREENOME HOLDINGS SER B CVT PFD PP | EP | Long | Modellwert (Stufe 2) | beschränkt | 4.550.161 $ | 0,04 | 1.558.570 | |
| PARABILIS MED INC SER D CVT PFD STOCK PP | FOG PHARMA SER D CVT PFD STOCK PP | EP | TC2VY7UZ1 | Long | Schätzwert (Stufe 3) | beschränkt | 4.470.988 $ | 0,04 | 615.203 |
| Kardium Inc Series D-8 CVT PFD Stock PP | KARDIUM INC SERIES D-8 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.392.791 $ | 0,04 | 6.786.958 | |
| Deepsight Tech Inc SER C CVT PFD PP | Deepsight Tech Inc SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.378.728 $ | 0,04 | 342.294 | |
| SPAC PCSC Freenome PIPE COMMIT PP | SPAC PCSC FREENOME PIPE COMMIT PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 4.326.131 $ | 0,04 | 438.178 | |
| Genesis Molecular AI Ser A CVT PFD PP | GENESIS THERA SER A CVT PFD STOCK PP | EP | TC08XH789 | Long | Schätzwert (Stufe 3) | beschränkt | 4.236.305 $ | 0,04 | 829.412 |
| ENTRADA THERAPEUTICS INC | ENTRADA THERAPEUTICS INC | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 4.154.920 $ | 0,04 | 329.233 | |
| CRESCENT BIOPHARMA INC | CRESCENT BIOPHARMA INC | EC | KYG2545C1042 | Long | Börsenkurs (Stufe 1) | 4.060.964 $ | 0,04 | 221.065 | |
| ZAI LAB LTD ADR | ZAI LAB LTD | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 4.009.803 $ | 0,04 | 213.174 | |
| Eikon Therapeutics, Inc Lockup Shs PP | Eikon Therapeutics, Inc. IPO lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 3.929.856 $ | 0,04 | 371.442 | |
| PARABILIS MED INC SER E CVT PFD STOCK PP | FOG PHARMA SER E CVT PFD PP | EP | TC0O5RRO6 | Long | Schätzwert (Stufe 3) | beschränkt | 3.841.759 $ | 0,04 | 623.217 |
| TECTONIC THERAPEUTIC INC | TECTONIC THERAPEUTIC INC | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 3.778.871 $ | 0,03 | 122.254 | |
| EIKON THERAPEUTICS INC | EIKON THERAPEUTICS INC | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 3.693.457 $ | 0,03 | 349.098 | |
| MANUS BIO INC SERIES ONE-6 CVT PFD PP | Manus Bio, Inc Series One-6 | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.669.312 $ | 0,03 | 1.223.104 | |
| PARABILIS MED INC SER C CVT PFD STOCK PP | FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | EP | TC4W1BVL4 | Long | Schätzwert (Stufe 3) | beschränkt | 3.624.245 $ | 0,03 | 431.391 |
| TESSERA THERAPEUTICS SER C' CVT PFD PP | Tessera Therapeutics, Inc. Series C | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.492.221 $ | 0,03 | 674.174 | |
| BICYCLE THERAPEUTICS PLC-ADR | BICYCLE THERAPEUTICS PLC | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 3.430.125 $ | 0,03 | 739.251 | |
| GENERATE BIOMEDICINES INC | GENERATE BIOMEDICINES INC | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 3.320.513 $ | 0,03 | 265.641 | |
| IMMUNEERING CORP - CLASS A | IMMUNEERING CORP | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 3.288.617 $ | 0,03 | 624.026 | |
| ENDEAVOR BIO SER C CVT PFD PP | ENDEAVOR BIO SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.195.495 $ | 0,03 | 489.761 | |
| GALVANIZE THERA SER C-1 CVT PFD PP | Galvanize Therapeutics Series C-1 CVT PFD | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.165.891 $ | 0,03 | 7.721.685 | |
| BridgeBio Oncology Therapeutics Inc | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 2.984.691 $ | 0,03 | 333.485 | |
| IMMIX BIOPHARMA INC | IMMIX BIOPHARMA INC | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 2.973.513 $ | 0,03 | 326.401 | |
| Kartos Therapeutics SR D CVT PFD STK PP | KARTOS THERAPEUTICS SR D CVT PFD STK PP | EP | TC82Z0AE2 | Long | Schätzwert (Stufe 3) | beschränkt | 2.904.082 $ | 0,03 | 513.724 |
| ARBOR BIO SERIES B CVT PFD STOCK PP | ARBOR BIO SERIES B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.834.278 $ | 0,03 | 532.759 | |
| EVOMMUNE INC PIPE PP | EVOMMUNE INC PIPE PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 2.738.733 $ | 0,03 | 125.397 | |
| FREENOME HOLDINGS SER C CVT PFD PP | FREENOME HOLDINGS SER C CVT PFD PP | EP | TC87S2BF1 | Long | Modellwert (Stufe 2) | beschränkt | 2.709.920 $ | 0,02 | 928.231 |
| LUMICKS TECH SER D CVT PFD STOCK PP | LUMICKS TECH SER D CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.670.107 $ | 0,02 | 4.954 | |
| DNA SCRIPT SERIES C CVT PFD STOCK PP | DNA SCRIPT SERIES C CVT PFD STOCK PP | EP | TC3XW4UW2 | Long | Schätzwert (Stufe 3) | beschränkt | 2.609.920 $ | 0,02 | 25.201 |
| PAX LABS CLASS A COMMON PP | PAX LABS CLASS A COMMON PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 2.603.376 $ | 0,02 | 8.397.988 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUTICALS INC | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 2.375.576 $ | 0,02 | 70.221 | |
| SALUDA MEDICAL INC | SALUDA MEDICAL INC | EC | AU0000432114 | Long | Modellwert (Stufe 2) | 2.275.357 $ | 0,02 | 3.958.452 | |
| Mirum Pharma Indemnity Holdback Shs PP | Mirum Pharma Indemnity Holdback Shs PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 2.205.083 $ | 0,02 | 25.126 | |
| Treeline Bio SER A-2 CVT PFD PP | TREELINE BIO SER A-2 NV CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.182.078 $ | 0,02 | 299.448 | |
| ENLIVEN THERAPEUTICS INC | ENLIVEN THERAPEUTICS INC | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 2.111.430 $ | 0,02 | 53.863 | |
| Saluda Medical Inc Lockup Shs CDI PP | SALUDA MEDICAL INC PP restricted cdi | EC | Long | Modellwert (Stufe 2) | beschränkt | 2.101.925 $ | 0,02 | 3.715.230 | |
| HIMS & HERS HEALTH INC | HIMS & HERS HEALTH INC | EC | 433000106 | Long | Börsenkurs (Stufe 1) | 2.027.172 $ | 0,02 | 97.648 | |
| IMMUNOVANT INC | IMMUNOVANT INC | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 2.022.647 $ | 0,02 | 81.427 | |
| TESSERA THERAPEUTICS SER D CVT PFD PP | TESSERA THERAPEUTICS SER D CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.978.703 $ | 0,02 | 381.989 | |
| MONOPAR THERAPEUTICS INC | MONOPAR THERAPEUTICS INC | EC | 61023L207 | Long | Börsenkurs (Stufe 1) | 1.886.310 $ | 0,02 | 34.428 | |
| COLOR HEALTH SERIES E CVT PFD STOCK PP | COLOR HEALTH SERIES E CVT PFD STOCK PP | EP | TC4SC4HB5 | Long | Schätzwert (Stufe 3) | beschränkt | 1.810.109 $ | 0,02 | 44.149 |
| ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | EP | TC4CBMMO7 | Long | Schätzwert (Stufe 3) | beschränkt | 1.763.146 $ | 0,02 | 1.115.915 |
| Delfi Diagnostics CVT Prom Note PP | DELFI DIAGNOSTICS CVT PROM NOTE PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 1.732.158 $ | 0,02 | 1.732.158 | |
| ARBOR BIO SERIES C CVT PFD STOCK PP | ARBOR BIO SERIES C CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.713.551 $ | 0,02 | 322.096 | |
| SAIL BIOMEDICINES SER B CVT PFD STOCK PP | LARONDE SERIES B CVT PFD STOCK PP | EP | TC14DLDG5 | Long | Schätzwert (Stufe 3) | beschränkt | 1.684.637 $ | 0,02 | 1.169.887 |
| ROCKET PHARMACEUTICALS INC | ROCKET PHARMACEUTICALS INC | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 1.663.368 $ | 0,02 | 464.628 | |
| CABALETTA BIO INC | CABALETTA BIO INC | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 1.636.868 $ | 0,02 | 608.501 | |
| ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | EP | TC141T8S1 | Long | Schätzwert (Stufe 3) | beschränkt | 1.561.515 $ | 0,01 | 281.354 |
| ELEMENT BIOSCIENCES SER D CVT PFD PP | ELEMENT BIOSCIENCES SER D CVT PFD PP | EP | TC3OATBR3 | Long | Schätzwert (Stufe 3) | beschränkt | 1.561.515 $ | 0,01 | 281.354 |
| FREENOME HOLDINGS SER D CVT PFD PP | FREENOME HOLDINGS SER D CVT PFD PP | EP | Long | Modellwert (Stufe 2) | beschränkt | 1.537.100 $ | 0,01 | 526.504 | |
| ADLAI NORTYE LTD-ADR | ADLAI NORTYE LTD | EC | 00704R109 | Long | Börsenkurs (Stufe 1) | 1.520.082 $ | 0,01 | 219.665 | |
| AURA BIOSCIENCES INC | AURA BIOSCIENCES INC | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 1.479.393 $ | 0,01 | 221.135 | |
| RING THERAPEUTICS INC PP | RING THERAPEUTICS INC PP | EC | TC4CR9CB8 | Long | Schätzwert (Stufe 3) | beschränkt | 1.341.838 $ | 0,01 | 291.704 |
| AVALYN PHARMA SER D CVT PFD STOCK PP | AVALYN PHARMA SER D CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.326.922 $ | 0,01 | 1.666.360 | |
| LENZ THERAPEUTICS INC | LENZ THERAPEUTICS INC | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 1.324.472 $ | 0,01 | 144.751 | |
| VERILY LIFE SCIENCES LLC SER B UNITS PP | VERILY LIFE SCIENCES LLC SER B UNITS PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 1.265.989 $ | 0,01 | 113.564 | |
| CLEAR LABS SER D CVT PFD STOCK PP | CLEAR LABS SER D CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.183.027 $ | 0,01 | 379.601 | |
| BETA BIONICS INC | BETA BIONICS INC | EC | 08659B102 | Long | Börsenkurs (Stufe 1) | 1.133.523 $ | 0,01 | 113.126 | |
| Mirum Pharma Escrow Indemnity PP | Mirum Pharma Escrow Indemnity PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 1.133.167 $ | 0,01 | 1.192.808 | |
| RADNET INC | RADNET INC | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 1.008.144 $ | 0,01 | 18.038 | |
| MEDIWOUND LTD | MEDIWOUND LTD | EC | IL0011316309 | Long | Börsenkurs (Stufe 1) | 1.001.736 $ | 0,01 | 62.181 | |
| ANNEXON INC | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 978.464 $ | 0,01 | 176.618 | |
| HONOR TECHNOLOGY SER D CVT PFD PP | HONOR TECHNOLOGY SER D CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 939.282 $ | 0,01 | 3.130.941 | |
| CAPSULE CORP SERIES E CVT PFD STOCK PP | CAPSULE CORP SERIES E CVT PFD STOCK PP | EP | TC0YJ3TD4 | Long | Schätzwert (Stufe 3) | beschränkt | 915.723 $ | 0,01 | 906.656 |
| CAPSULE CORP SERIES 1-D CVT PFD STOCK | CAPSULE CORP SERIES 1-D CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 861.745 $ | 0,01 | 853.213 | |
| NUVATION BIO INC | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 800.154 $ | 0,01 | 186.516 | |
| Kartos Therapeutics CVT Prom Note PP | KARTOS THERAPEUTICS CVT PROM NOTE PP | DBT | TC9IB1JR2 | Long | Schätzwert (Stufe 3) | beschränkt | 741.016 $ | 0,01 | 741.016 |
| PROFOUNDBIO ESCROW FUND PAYMENT PP | PROFOUNBIO ESCROW FUND PAYMENT | EP | Long | Schätzwert (Stufe 3) | beschränkt | 669.262 $ | 0,01 | 704.486 | |
| Odyssey Therapeutics SER D CVT Pfd Stk PP | ODYSSEY THERAPEUTICS SER D CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 668.940 $ | 0,01 | 444.487 | |
| Reflexion Med CVT Note issued 072525 PP | REFLEXION MEDICAL CVT PROM NOTE PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 656.772 $ | 0,01 | 239.698 | |
| Reflexion Med CVT Note issued 081325 PP | REFLEXION MED CVT PROM NOTE 081325 PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 651.979 $ | 0,01 | 239.698 | |
| Reflexion Med CVT Note issued 082725 PP | REFLEXION MED CVT NOTE ISSUED 082725 PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 647.185 $ | 0,01 | 239.698 | |
| HONOR TECHNOLOGY SER E CVT PFD STOCK PP | HONOR TECHNOLOGY SER E CVT PFD STOCK PP | EP | TC2V4FT13 | Long | Schätzwert (Stufe 3) | beschränkt | 628.742 $ | 0,01 | 2.095.807 |
| FREENOME HOLDINGS SER F CVT PFD PP | FREENOME HOLDINGS SER F CVT PFD PP | EP | TC17ZDYA2 | Long | Modellwert (Stufe 2) | beschränkt | 521.725 $ | 0,00 | 178.707 |
| REVOLUTION MEDICINES INC WTS 12/26 | REVOLUTION MEDICINES INC | EC | 76155X118 | Long | Börsenkurs (Stufe 1) | 345.399 $ | 0,00 | 198.505 | |
| Treeline Bio Common WTS 8/35 PP | TREELINE BIO COMMON WTS 8.35 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 327.310 $ | 0,00 | 44.917 | |
| Cabaletta Bio Common WTS 09/26 PP | CABALETTA BIO COMMON WTS 09/26 PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 321.927 $ | 0,00 | 1.694.355 | |
| JANUX THERAPEUTICS INC | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 314.126 $ | 0,00 | 22.599 | |
| Chromacode INC SER AA CVT PFD STK PP | CHROMACODE INC SER AA CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 178.322 $ | 0,00 | 36.845 | |
| ODYSSEY THERAPEUTICS SR C CVT PFD STK PP | ODYSSEY THERAPEUTICS SR C CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 159.384 $ | 0,00 | 105.905 | |
| GINKGO BIOWORKS HOLDINGS INC | GINKGO BIOWORKS HOLDINGS INC | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 144.362 $ | 0,00 | 23.550 | |
| PROGNOMIQ INC CL A Common PP | PROGNOMIQ INC PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 90.997 $ | 0,00 | 606.647 | |
| Mirum Pharma Escrow Working Capital PP | Mirum Pharma Escrow Working Capital PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 45.692 $ | 0,00 | 48.097 | |
| Mirum Pharma Escrow Expense Fund PP | Mirum Pharma Escrow Expense Fund PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 45.692 $ | 0,00 | 48.097 | |
| AFFINIVAX EXPENSE FUND PP | AFFINIVAX EXPENSE FUND PP | EC | TC929D1E2 | Long | Schätzwert (Stufe 3) | beschränkt | 11.563 $ | 0,00 | 12.445 |
| REFLEXION MEDICAL INC CVT PFD SR C-X PP | REFLEXION MEDICAL INC CVT PFD SR C PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.260 $ | 0,00 | 2.507.885 | |
| CHROMACODE INC PP | CHROMACODE INC PP | EC | TC43UPY99 | Long | Schätzwert (Stufe 3) | beschränkt | 3.030 $ | 0,00 | 626 |
| REFLEXION MEDICAL INC CVT PFD SR E-X PP | REFLEXION MEDICAL INC SR E CVT PFD PP | EP | TC9L8ZXJ6 | Long | Schätzwert (Stufe 3) | beschränkt | 2.600 $ | 0,00 | 1.857.286 |
| REFLEXION MEDICAL SER F CVT PFD STOCK PP | REFLEXION MEDICAL INC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.794 $ | 0,00 | 1.794.104 | |
| GENEDX HOLDINGS CORP WTS 7/26 | GENEDX HOLDINGS CORP | EC | 81663L119 | Long | Börsenkurs (Stufe 1) | 1.654 $ | 0,00 | 206.747 | |
| REFLEXION MEDICAL INC CVT PFD SR D-X PP | REFLEXION MEDICAL INC CVT | EP | TC70GKL85 | Long | Schätzwert (Stufe 3) | beschränkt | 1.460 $ | 0,00 | 1.123.437 |
| PROFOUNDBIO EXPENSE FUND PAYMENT PP | PROFOUNDBIO EXPENSE FUND PYMT | EP | Long | Schätzwert (Stufe 3) | beschränkt | 470 $ | 0,00 | 2.348 | |
| Blue Marlin Therapeutics Common Stock PP | BLUE MARLIN THERAPEUTICS COMMON STOCK PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 180 $ | 0,00 | 1.803 | |
| EXACT SCIENCES CMO MILESTONE PP | - EXACT SCIENCES CMO MILESTONE PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.726.272 | |
| GINKGO BIOWORKS HLDS ERN OUT SHS 600 PP | Ginkgo Bioworks Holdings Earn Out Shares $15.00 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| NUTCRACKER THERA SER C CVT PFD STOCK PP | NUTCRACKER THERA SER C CVT PFD STOCK PP | EP | TC3WVBUQ2 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 1.027.785 |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 3 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 3 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.788.007 | |
| SOMALOGIC INC WTS 8/26 | SOMALOGIC INC | EC | 83444K113 | Long | Modellwert (Stufe 2) | 0 $ | 0,00 | 90.179 | |
| Mirum Pharma Milestone $500 mil PP | Mirum Pharma Milestone $500 mil PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.428.195 | |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 1 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 1 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.683.928 | |
| Odyssey Therapeutics Warrants 6/32 WRT PP | ODYSSEY THERAPEUTICS WARRANTS 6/32 WRT PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 133.346 | |
| GENERATION BIO CO | GENERATION BIO CO | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 102.601 | ||
| Saluda Med Common WTS 3/26 PP | SALUDA MEDICAL WTS COMMON STOCK | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 2 | |
| AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | EC | TC7BEY6E7 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 7.349.672 |
| AFFINIVAX AFX3772 MILESTONE EVENT PP | AFFINIVAX AFX3772 MILESTONE EVENT PP | EC | TC2HD0ET2 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 7.349.672 |
| EXACT SCIENCES FDA MILESTONE PP | EXACT SCIENCES FDA MILESTONE PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 1.863.136 | |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 2 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 2 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.788.007 | |
| Mirum Pharma Milestone $750 mil PP | Mirum Pharma Milestone $750 mil PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.713.658 | |
| GINKGO BIOWORKS HLDS ERN OUT SH 800 PP | Ginkgo Bioworks Holdings Earn Out Shares $20.00 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| GINKGO BIOWORKS HLDS ERN OUT SHS 700 PP | Ginkgo Bioworks Holdings Earn Out Shares $17.50 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| 10.850.119.651 $ | 99,60 | 407.026.215 |